Lentiviral human AZI2 shRNA (EF1a)

Catalog number
HSH-320361
Kit Components
Lentiviral particles or plasmids for 3 unique target specific shRNA and 1 scramble shRNA, RT-PCR primer mix for target specific gene and a housekeeping gene

To order

  1. HSH-320361-25

    Lentiviral human AZI2 shRNA (EF1a) (25)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, 25 ul each, functional titer of 1x10^8 TU/ml
    $980.00
  2. HSH-320361-100

    Lentiviral human AZI2 shRNA (EF1a) (100)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, 4x25 ul each, functional titer of 1x10^8 TU/ml
    $2,190.00
  3. HSH-320361-10ug

    Lentiviral human AZI2 shRNA (EF1a) plasmid

    Lentiviral constructs for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, 10 ug each
    $1,290.00
  4. HSH-320361-25GFP

    Lentiviral human AZI2 shRNA (EF1a,GFP) (25)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a GFP reporter, 25 ul each, functional titer of 1x10^8 TU/ml
    $980.00
  5. HSH-320361-100GFP

    Lentiviral human AZI2 shRNA (EF1a,GFP) (100)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a GFP reporter, 4x25 ul each, functional titer of 1x10^8 TU/ml
    $2,190.00
  6. HSH-320361-10ugGFP

    Lentiviral human AZI2 shRNA (EF1a,GFP) plasmid

    Lentiviral constructs for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a GFP reporter, 10 ug each
    $1,290.00
  7. HSH-320361-25RFP

    Lentiviral human AZI2 shRNA (EF1a,RFP) (25)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a RFP reporter, 25 ul each, functional titer of 1x10^8 TU/ml
    $980.00
  8. HSH-320361-100RFP

    Lentiviral human AZI2 shRNA (EF1a,RFP) (100)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a RFP reporter, 4x25 ul each, functional titer of 1x10^8 TU/ml
    $2,190.00
  9. HSH-320361-10ugRFP

    Lentiviral human AZI2 shRNA (EF1a,RFP) plasmid

    Lentiviral constructs for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a RFP reporter, 10 ug each
    $1,290.00
  10. HSH-320361-25iRFP

    Lentiviral human AZI2 shRNA (EF1a,iRFP) (25)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a miRFP670 reporter, 25 ul each, functional titer of 1x10^8 TU/ml
    $980.00
  11. HSH-320361-100iRFP

    Lentiviral human AZI2 shRNA (EF1a,iRFP) (100)

    Lentiviral particles for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a miRFP670 reporter, 4x25 ul each, functional titer of 1x10^8 TU/ml
    $2,190.00
  12. HSH-320361-10ugiRFP

    Lentiviral human AZI2 shRNA (EF1a,iRFP) plasmid

    Lentiviral constructs for 3 unique target specific shRNA and 1 scramble shRNA driven by the EF1a promoter, with a miRFP670 reporter, 10 ug each
    $1,290.00

Product Details

Target gene information

Gene symbolAZI2
SynonymsAZ2 NAP1 TILP
Specieshuman
Gene ID64343
SummaryAZI2, or NAP1, contributes to the activation of NFKB (see MIM 164011)-dependent gene expression by activating IKK-related kinases, such as NAK (TBK1; MIM 604834) (Fujita et al., 2003 [PubMed 14560022]).[supplied by OMIM, Mar 2008].

shRNA lentiviral particle information

Functional titer1x10^8 TU/ml
Titration methodcounting puromycin resistant cell clones
PurityIn vivo grade
PseudotypeVSV-G
Storage bufferLentiShield™Lentivirus storage buffer
Storage condition-80°C
Availability3-4 weeks

shRNA lentiviral plasmid information

Target shRNAHuman AZI2 shRNA
Promoter for target shRNAEF1a
Mammalian selectionPuromycin
Promoter for mammalian selection genePGK
E.coli selectionAmp
Storage condition-20°C
Availability1-2 weeks
Copyright © 2025, FenicsBIO. All rights reserved.